Moderna enters separation agreement with former CFO; includes clawback tied to Dentsply probe

Moderna, Inc.

CFO Jorge Gomez departed May 10; separation agreement signed May 13, 2022.
Severance of $700K salary (12 months) plus 12 months COBRA premium assistance.
Company can claw back benefits if Gomez is found to have engaged in wrongdoing or faces fines in Dentsply/SEC investigation.
Gomez released all claims against Moderna; non-compete waived; other restrictive covenants remain.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jorge Gomez

Chief Financial Officer

MRNA · Moderna, Inc.

Effective: 2022-05-10
Filed: May 13, 2022, 7:59 PM ET

Jorge Gomez departed from the role of Chief Financial Officer of the Company

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jorge Gomez departed as Chief Financial Officer at Moderna, Inc..

Action: departed
Role: Chief Financial Officer

Exact text from the filing

Jorge Gomez departed from the role of Chief Financial Officer of the Company

View on SEC.gov

Moderna, Inc. filing history →

Source: SEC EDGAR

accession 0001682852-22-000029

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.